Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.
about
The utility of transposon mutagenesis for cancer studies in the era of genome editing.A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorMouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studiesEpigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumorsSimple and efficient methods for enrichment and isolation of endonuclease modified cellsCo-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.Discovery of co-occurring driver pathways in cancerGenome-wide Twist1 occupancy in endocardial cushion cells, embryonic limb buds, and peripheral nerve sheath tumor cells.Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection.New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.Sequencing methods and datasets to improve functional interpretation of sleeping beauty mutagenesis screens.Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2.Case-oriented pathways analysis in pancreatic adenocarcinoma using data from a sleeping beauty transposon mutagenesis screen.A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with OsteosarcomaSleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.RNA sequencing of Sleeping Beauty transposon-induced tumors detects transposon-RNA fusions in forward genetic cancer screensA Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionTransposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim inductionPreclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis.Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.Cancer gene discovery: exploiting insertional mutagenesis.Mechanism-based cancer therapy: resistance to therapy, therapy for resistance.Psychiatric disturbances regulate the innate immune system in CSF of conscious mice.Sleeping Beauty transposon insertional mutagenesis based mouse models for cancer gene discoveryPVT1 dependence in cancer with MYC copy-number increase.Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.Immortalization of human normal and NF1 neurofibroma Schwann cells.An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
P2860
Q26781762-10A14ED9-AE0A-4296-B00B-0A60BF498878Q27003534-0A2466F8-89F4-4922-B135-B901413D97B6Q27008537-122EF69A-F3B1-462E-8A55-FB74CEA4B614Q28080040-525CC6BD-899E-4DB7-A0DF-2FA809581D8CQ28538480-4C2AC8E1-A5B9-425B-B18C-0F93B9EB4853Q33688908-74D3C4D2-481C-4033-9358-9FAC1F095DCAQ33826589-8E86C482-AC0D-4412-ABEB-6AD31CC955C5Q34048409-8D22F1BC-DFB2-4765-B26F-FA1CCD54F82AQ34308984-95E433F6-D9E7-4DB6-9050-78A4870A385EQ34467060-7A65CC4F-9A53-45A6-BA07-88D0398C120BQ34515911-0D3E2A98-66E8-4271-9E31-4129502DEFBBQ35229905-E6E1CEB2-3BC2-46FF-BF8F-61065C513D13Q35558868-1EB8D3D4-D9BD-4FD0-9EDF-708B7BC86E90Q35922216-ECC24D1A-D904-4458-AF56-A8D82403A06AQ35977938-465A34BA-3FDF-44C6-A974-E3F29B0CFC3AQ36029709-87A7D7F6-E847-4999-9FF9-35CEC1865774Q36214663-2F747ECF-A388-49E2-A71C-5E962B8936FBQ36269684-B6D1DE31-92FC-488C-AD66-22FA4E45846DQ36406058-A690A12B-989F-4A0B-9A7C-400EAF457C1FQ36617953-AF41DF9B-18EA-4528-8F8A-EC87F4D33AC1Q36663582-1AC1350C-6E65-440F-8C27-540C143F830CQ36753692-231A3CC4-4F82-4981-B4FC-B12B2CFE8F36Q36844285-BBD55DCB-B80D-4D92-9598-1EAA5D25E06AQ37097265-9FD4078B-9163-4B7C-9483-73303922288BQ37217432-92D437E2-C556-4C8E-A3C8-7627F1014D44Q37225412-E547FD42-43A7-4982-9DB0-3D60E77C36BAQ37473990-3DDB29DC-174A-4A39-B471-56E9C4577286Q37523017-9DCB9371-29B2-40FA-A182-AC10377F99B0Q37625501-B6801193-A4E7-4417-AE12-3D83484CAFD5Q37708727-6DDC7E12-974E-40C9-BD22-74E29C8789ABQ37711615-C4AB7B10-DC6C-4463-A20D-7B48AA025E76Q38127512-67BF5FBF-7B87-4CB1-B60B-293977FAFAB7Q38255064-6B020794-6B1E-4208-B83B-3CA206E56850Q38517137-2DE83E63-134C-40F4-9520-946FBAD72665Q38519256-FB3CDF3B-AC0B-448C-B4C0-DA772312F888Q38628939-DD09EDCE-F0E7-48AA-B94C-6B2BF30AA663Q38738733-ABD22274-FA9D-4B92-9CE8-3D7A9695F859Q38746881-A4909F1C-0A88-4733-9F83-000A9378DC7FQ38762824-FEA718D5-373B-40D1-B23E-5CF2FAC6240DQ38792018-C7C71691-FD64-4BC6-BC84-4E1319F1EFF3
P2860
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Forward genetic screen for mal ...... athways driving tumorigenesis.
@en
Forward genetic screen for mal ...... athways driving tumorigenesis.
@nl
type
label
Forward genetic screen for mal ...... athways driving tumorigenesis.
@en
Forward genetic screen for mal ...... athways driving tumorigenesis.
@nl
prefLabel
Forward genetic screen for mal ...... athways driving tumorigenesis.
@en
Forward genetic screen for mal ...... athways driving tumorigenesis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Forward genetic screen for mal ...... athways driving tumorigenesis.
@en
P2093
Aaron Sarver
Adrienne L Watson
Branden S Moriarity
Christopher L Moertel
David A Largaespada
Dominic A Beckmann
Eric P Rahrmann
Kwangmin Choi
Margaret H Collins
Margaret R Wallace
P2860
P2888
P304
P356
10.1038/NG.2641
P407
P577
2013-05-19T00:00:00Z